CDK2-IN-41
CDK2-IN-41 (Compound 7a) is a potent CDK2 inhibitor that induces cell cycle arrest, apoptosis, and ROS generation in cancer cells. It demonstrates in vitro anticancer activity against acute myeloid leukemia (AML) HL-60 cells with an IC50 of 10 μM, making it a useful research tool for studying AML and related oncologies.
Product Specifications
Field of Research
Cell Biology, Epigenetics & Chromatin, Immunology & Inflammation, Metabolism Research, Signal Transduction
Molecular Formula
C19H21N3S
Molecular Weight
323.46
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog